Our Solutions

Newsletters

NEWSLETTERS

  • November 2014

    Newsletter

    November 2014

    Nov 1, 2014

    The impact of new partial AUC parameters for evaluating the bioequivalence of prolonged-release formulations, Thank you to everyone who joined us at the AAPS Annual Meeting in San Diego and Don't miss the 7th EBF Open…

  • October 2014

    Newsletter

    October 2014

    Oct 1, 2014

    Development and Validation of an ELISA for the Determination of AB-16B5 in Rat Serum, AAPS Annual Meeting, San Diego, Webinar — Impaired Renal Function Clinical Trials: Early Phase Planning to Minimize Risks and…

  • September 2014

    Newsletter

    September 2014

    Sep 1, 2014

    Biologics & Biosimilars: Key Considerations & Strategies in Early Stage Development and Overcoming the Bioanalysis Challenges of Biosimilars: Rituximab Case Study.

  • August 2014

    Newsletter

    August 2014

    Aug 1, 2014

    Improving Patient Recruitment for Early Phase Clinical Trials, Customizable First-In-Human Trial Gantt Chart and Bioanalysis Journal: Choosing the appropriate matrix to perform a scientifically meaningful lipemic plasma…

  • June 2014

    Newsletter

    June 2014

    Jun 1, 2014

    Customize in Real-Time: First-In-Human (FIH) Trial Gantt Chart, Webinar Recording Available and 2014 CSPS Annual Conference Recordings.

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.

Working as a flexible, attentive extension of your team, we offer all you need to move your molecule forward.